![Carsten Boess](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carsten Boess
Direktor/Vorstandsmitglied bei
ROCKET PHARMACEUTICALS, INC.
Vermögen: - $ am 31.05.2026
Profil
Carsten Boess was the founder of Kiniksa Pharmaceuticals Ltd., founded in 2015, where the title held was Executive Vice President-Corporate Affairs from 2015 to 2020.
Current jobs include Director at Atrium Therapeutics, Inc. since 2026, Independent Director at Rocket Pharmaceuticals, Inc. since 2016, and Independent Non-Executive Director at Achilles Therapeutics Plc since 2020.
Former jobs include Non-Executive Director at Achilles Therapeutics UK Ltd. from 2020 to 2021, Senior Director-Finance & Information Technology at Novozymes A, Independent Director at Inotek Pharmaceuticals Corp., Independent Director at Health Sciences Acquisitions Corp.
2, Independent Director at Avidity Biosciences, Inc. from 2020 to 2026, Chief Financial Officer at Alexion Pharmaceuticals, Inc. from 2004 to 2005, Vice President-Finance & International Operations at Novo Nordisk A from 1991 to 2004, Executive Vice President-Finance at EMD Serono, Inc. from 2005 to 2006, Manager-Investor Relations & Finance at Novo Nordisk North America, Inc., and Chief Financial Officer & Senior Vice President at Synageva BioPharma Corp.
from 2011 to 2015.
Education includes undergraduate and graduate degrees from the University of Southern Denmark.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 | |
-.--% | 27.02.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Carsten Boess
| Unternehmen | Position | Beginn |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.01.2016 |
| ACHILLES THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 01.04.2020 |
Ehemalige bekannte Positionen von Carsten Boess
| Unternehmen | Position | Ende |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 27.02.2026 |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Direktor/Vorstandsmitglied | 11.01.2021 |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Gründer | 01.02.2020 |
| SYNAGEVA BIOPHARMA CORP | Finanzdirektor/CFO | 01.01.2015 |
| INSULET CORPORATION | Finanzdirektor/CFO | 05.03.2009 |
Ausbildung von Carsten Boess
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Novozymes A/S
 Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Process Industries |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye | Health Technology |
Avidity Biosciences, Inc.
 Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Insulet Corp.
 Insulet Corp. Medical SpecialtiesHealth Technology Manufactures, develops and markets insulin infusion systems | Health Technology |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
University of Southern Denmark
 University of Southern Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk North America, Inc. | |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Health Technology |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Health Sciences Acquisitions Corp. 2
 Health Sciences Acquisitions Corp. 2 Financial ConglomeratesFinance Operates as a blank check company | Finance |
Achilles Therapeutics Plc
 Achilles Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and sells cancer immunotherapies | Health Technology |
